Company Filing History:
4 out of 5,076 
4 out of 278 
Years Active: 2009-2015
Title: Innovator Nicolas Gabriel Albert Manel: Advancements in Cancer Diagnostics
Introduction
Nicolas Gabriel Albert Manel is a prominent inventor based in Montpellier, France, known for his significant contributions to the field of biomedical research. With a total of four patents to his name, he focuses on innovative solutions for cancer diagnostics and therapeutic interventions related to PTLV (Primates T-Lymphotropic Viruses).
Latest Patents
Manel's latest patents demonstrate his commitment to advancing medical science. One notable invention is the use of the glucose transporter GLUT1 as a receptor for HTLV (Human T-cell Lymphotropic Virus) envelopes. This invention outlines methods for in vitro cancer diagnosis by utilizing GLUT1 as a tumor marker. It also includes the development of pharmaceutical compositions aimed at treating pathologies associated with PTLV infections, leveraging GLUT1’s properties.
Another significant patent involves oligonucleotides derived from sequences coding for surface components of PTLV envelope proteins. This invention focuses on methods for detecting various PTLV strains and related viruses, including new variants, ultimately enhancing early diagnostic capabilities.
Career Highlights
Nicolas Manel has collaborated with leading research institutions such as the National Centre for Scientific Research (Centre National De La Recherche Scientifique) and the University of Montpellier. His work reflects a dedication to scientific excellence and innovation in the pursuit of effective medical solutions.
Collaborations
Throughout his career, Manel has collaborated with fellow researchers and inventors, including Felix Jinhyun Kim and Jean-Luc Georges Laurent Battini. These partnerships have enabled him to expand his research and enhance the impact of his inventions in the biomedical field.
Conclusion
Nicolas Gabriel Albert Manel stands out as a visionary inventor making substantial contributions to cancer diagnostics and treatment through his innovative patents. His work continues to inspire advancements in medical research, highlighting the importance of collaboration and creativity in tackling complex health challenges.